Human P450 CYP17A1: Control of Substrate Preference by Asparagine 202

被引:8
|
作者
Gregory, Michael C. [1 ]
Mak, Piotr J. [2 ,4 ]
Khatri, Yogan [1 ,5 ]
Kincaid, James R. [2 ]
Sligar, Stephen G. [1 ,3 ]
机构
[1] Univ Illinois, Dept Biochem, 505 South Goodwin Ave, Urbana, IL 61801 USA
[2] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA
[3] Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA
[4] St Louis Univ, Dept Chem, 3501 Laclede Ave, St Louis, MO 63103 USA
[5] Univ Michigan, Life Sci Inst, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
NITRIC-OXIDE SYNTHASE; PHOSPHOLIPID-BILAYER NANODISCS; NEONATAL PIG TESTIS; RESONANCE RAMAN; CYTOCHROME B(5); MICROSOMAL CYTOCHROME-P-450; FUNCTIONAL-PROPERTIES; PROTEIN INTERACTIONS; ESCHERICHIA-COLI; LYASE;
D O I
10.1021/acs.biochem.7b01067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CYP17A1 is a key steroidogenic enzyme known to conduct several distinct chemical transformations on multiple substrates. In its hydroxylase activity, this enzyme adds a hydroxyl group at the 17 alpha position of both pregnenolone and progesterone at approximately equal rates. However, the subsequent 17,20 carbon-carbon scission reaction displays variable substrate specificity in the numerous CYP17A1 isozymes operating in vertebrates, manifesting as different K-d and k(cat) values when presented with 17 alpha-hydroxypregnenlone (OHPREG) versus 17 alpha-hydroxyprogesterone (OHPROG). Here we show that the identity of the residue at position 202 in human CYP17A1, thought to form a hydrogen bond with the A-ring alcohol substituent on the pregnene-nucleus, is a key driver of this enzyme's native preference for OHPREG. Replacement of asparagine 202 with serine completely reverses the preference of CYP17A1, more than doubling the rate of turnover of the OHPROG to androstenedione reaction and substantially decreasing the rate of formation of dehydroepiandrosterone from OHPREG. In a series of resonance Raman experiments, it was observed that, in contrast with the case for the wild-type protein, in the mutant the 17 alpha alcohol of OHPROG tends to form a H-bond with the proximal rather than terminal oxygen of the oxy-ferrous complex. When OHPREG was a substrate, the mutant enzyme was found to have a H-bonding interaction with the proximal oxygen that is substantially weaker than that of the wild type. These results demonstrate that a single-point mutation in the active site pocket of CYP17A1, even when far from the heme, has profound effects on steroidogenic selectivity in androgen biosynthesis.
引用
收藏
页码:764 / 771
页数:8
相关论文
共 50 条
  • [41] Human cytochrome P450 (CYP) genes:: recommendations for the nomenclature of alleles
    Ingelman-Sundberg, M
    Daly, AK
    Oscarson, M
    Nebert, DW
    PHARMACOGENETICS, 2000, 10 (01): : 91 - 93
  • [42] Organization of the human aromatase P450 (CYP19) gene
    Bulun, SE
    Takayama, K
    Suzuki, T
    Sasano, H
    Yilmaz, B
    Sebastian, S
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (01) : 5 - 9
  • [43] The effect of clarithromycin on human cytochrome p450 (CYP) enzymes.
    Bruce, MA
    Gorski, JC
    Liu, Y
    Hall, SD
    Haehner-Daniels, BD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 136 - 136
  • [44] Estrogen receptor-α mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17α-hydroxylase/17,20 lyase) expression
    Taniguchi, Fuminori
    Couse, John F.
    Rodriguez, Karina F.
    Emmen, Judith M. A.
    Poirier, Donald
    Korach, Kenneth S.
    FASEB JOURNAL, 2007, 21 (02): : 586 - 595
  • [45] Random chimeragenesis of rat and human P450 17α-hydroxylase
    Brock, BJ
    Waterman, MR
    FASEB JOURNAL, 1997, 11 (09): : A799 - A799
  • [46] Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2
    Kinzig-Schippers, M
    Fuhr, U
    Zaigler, M
    Dammeyer, J
    Rüsing, G
    Labedzki, A
    Bulitta, J
    Sörgel, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) : 262 - 274
  • [47] Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
    Pandey, Amit V.
    Kempna, Petra
    Hofer, Gaby
    Mullis, Primus E.
    Flueck, Christa E.
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (10) : 2579 - 2595
  • [48] Active site proton delivery and the lyase activity of human CYP17A1
    Khatri, Yogan
    Gregory, Michael C.
    Grinkova, Yelena V.
    Denisov, Ilia G.
    Sligar, Stephen G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (01) : 179 - 184
  • [49] Homology models and molecular Modeling of human retinoic acid metabolizing enzymes cytochrome P450 26A1 (CYP26A1) and P450 26131 (CYP26B1)
    Karlsson, Magnus
    Strid, Ake
    Sirsjo, Allan
    Eriksson, Leif A.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2008, 4 (06) : 1021 - 1027
  • [50] Identification of inhibitors of Cytochrome P450 (CYP) 1B1
    Roach, Tyler
    Kennedy, Larry
    FASEB JOURNAL, 2016, 30